PyInvesting

Market research

NUVA NuVasive Inc

NASDAQ USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
2B
P/E ratio
75.0
Analyst target
45
Dividend yield
0.0%
Beta
1.07

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

NuVasive, Inc is currently in a long term uptrend where the price is trading 13.0% above its 200 day moving average.

From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.2.

NuVasive, Inc's total revenue sank by 6.0% to $292M since the same quarter in the previous year.

Its net income has dropped by 94.3% to $2M since the same quarter in the previous year.

Finally, its free cash flow fell by 3.2% to $45M since the same quarter in the previous year.

Based on the above factors, NuVasive, Inc gets an overall score of 2/5.